Aptus Capital Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325 | Hold |
2
| – | – | ﹤0.01% | 1506 |
|
|
2025
Q1 | $343 | Sell |
2
-345
| -99% | -$59.2K | ﹤0.01% | 1422 |
|
|
2024
Q4 | $57.7K | Buy |
347
+345
| +17,250% | +$57.3K | ﹤0.01% | 1075 |
|
|
2024
Q3 | $344 | Hold |
2
| – | – | ﹤0.01% | 1219 |
|
|
2024
Q2 | $308 | Hold |
2
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q1 | $308 | Hold |
2
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q4 | $316 | Hold |
2
| – | – | ﹤0.01% | 901 |
|
|
2023
Q3 | $293 | Sell |
2
-36
| -95% | -$5.27K | ﹤0.01% | 891 |
|
|
2023
Q2 | $5.82K | Hold |
38
| – | – | ﹤0.01% | 709 |
|
|
2023
Q1 | $5.89K | Hold |
38
| – | – | ﹤0.01% | 711 |
|
|
2022
Q4 | $5.86K | Sell |
38
-2
| -5% | -$308 | ﹤0.01% | 719 |
|
|
2022
Q3 | $5K | Hold |
40
| – | – | ﹤0.01% | 698 |
|
|
2022
Q2 | $5K | Sell |
40
-1
| -2% | -$125 | ﹤0.01% | 601 |
|
|
2022
Q1 | $6K | Buy |
41
+39
| +1,950% | +$5.71K | ﹤0.01% | 617 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 554 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 535 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 556 |
|
|
2021
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 505 |
|